WallStreetZenWallStreetZen

NASDAQ: URGN
Urogen Pharma Ltd Stock Ownership - Who owns Urogen Pharma?

Insider buying vs selling

Have Urogen Pharma Ltd insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Jason Drew SmithGeneral Counsel2024-09-091,521$13.08
$19.89kSell
Mark SchoenbergChief Medical Officer2024-09-09859$13.08
$11.24kSell
Mark SchoenbergChief Medical Officer2024-06-105,153$13.08
$67.40kSell
Mark SchoenbergChief Medical Officer2024-03-1812,000$14.05
$168.60kSell
Mark SchoenbergChief Medical Officer2024-02-01758$15.78
$11.96kSell
Jason Drew SmithGeneral Counsel2024-02-013,328$15.78
$52.52kSell
Jason Drew SmithGeneral Counsel2024-02-011,248$15.78
$19.69kSell
Jason Drew SmithGeneral Counsel2024-02-01417$15.78
$6.58kSell
Mark SchoenbergChief Medical Officer2024-02-011,137$15.78
$17.94kSell
Mark SchoenbergChief Medical Officer2024-02-011,894$15.78
$29.89kSell

1 of 3

URGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when URGN insiders and whales buy or sell their stock.

URGN Shareholders

What type of owners hold Urogen Pharma Ltd stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Ran Nussbaum18.19%7,674,072$93.01MInsider
Rtw Investments LP8.43%3,557,347$43.12MInstitution
Adage Capital Partners GP LLC7.82%3,300,000$40.00MInstitution
Ra Capital Management LP7.31%3,083,430$37.37MInstitution
Great Point Partners LLC6.89%2,906,259$35.22MInstitution
Point72 Asset Management LP5.80%2,449,277$29.69MInstitution
Menora Mivtachim Holdings Ltd5.46%2,303,031$27.91MInstitution
Blackrock Inc5.20%2,193,950$26.59MInstitution
Cowen And Company LLC4.98%2,099,482$25.45MInstitution
Morgan Stanley4.36%1,838,706$22.29MInstitution

1 of 3

URGN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
URGN79.24%20.76%Net SellingNet Selling
TERN76.44%23.56%Net SellingNet Buying
XERS40.71%15.83%Net SellingNet Buying
FHTX70.95%14.36%Net SellingNet Selling
CDXC10.52%89.48%Net BuyingNet Buying

Urogen Pharma Stock Ownership FAQ

Who owns Urogen Pharma?

Urogen Pharma (NASDAQ: URGN) is owned by 90.58% institutional shareholders, 23.73% Urogen Pharma insiders, and 0.00% retail investors. Ran Nussbaum is the largest individual Urogen Pharma shareholder, owning 7.67M shares representing 18.19% of the company. Ran Nussbaum's Urogen Pharma shares are currently valued at $93.01M.

If you're new to stock investing, here's how to buy Urogen Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.